Drug Trial Radar · NCT00333125
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
Last checked: Nov 20, 2026Latest source record: Nov 18, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
319
Actual
Start
Apr 2006
Primary completion
Feb 2007
Study completion Feb 2007
Sponsor
- Lead sponsor
- Alcon ResearchIndustry
- Sponsor type
- Industry
- First posted
- Jun 2, 2006
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the intraocular pressure (IOP)-lowering efficacy and safety of two combination products in patients with open-angle glaucoma or ocular hypertension.
Conditions
- Glaucoma
- Ocular Hypertension
Interventions
Travoprost 40 mcg/ml + Timolol 5 mg/ml eye drops, solution (DuoTrav)Drug
One drop in the study eye(s) once daily, 9 PM, for 6 weeks
Dorzolamide 20 mg/ml + Timolol 5 mg/ml eye drops, solution (Cosopt)Drug
One drop in the study eye(s) twice daily for 6 weeks
Timolol VehicleOther
One drop in the study eye(s) once daily for 6 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Intra-Ocular Pressure (IOP)Time frame: 6 weeks
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.